Cassava Sciences, Inc.
SAVA
$3.10
$0.217.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -77.63% | -66.34% | -15.81% | 9.60% | -25.11% |
| Gross Profit | 77.63% | 66.34% | 15.81% | -9.60% | 25.11% |
| SG&A Expenses | -43.72% | -82.74% | 18.19% | -123.83% | 228.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -62.61% | -79.03% | -5.88% | -13.67% | 13.79% |
| Operating Income | 62.61% | 79.03% | 5.88% | 13.67% | -13.79% |
| Income Before Tax | 61.32% | -818.51% | -193.45% | -31.92% | -8.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 61.32% | -818.51% | -193.45% | -31.92% | -8.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.32% | -818.51% | -193.45% | -31.92% | -8.94% |
| EBIT | 62.61% | 79.03% | 5.88% | 13.67% | -13.79% |
| EBITDA | 62.72% | 79.26% | 5.56% | 13.46% | -14.47% |
| EPS Basic | 61.59% | -787.31% | -183.26% | -15.71% | 4.63% |
| Normalized Basic EPS | 63.05% | -3,583.33% | -182.46% | 25.42% | 0.86% |
| EPS Diluted | 61.59% | -807.69% | -14.07% | -14.60% | 4.63% |
| Normalized Diluted EPS | 63.05% | -3,583.33% | -184.57% | 25.42% | 0.86% |
| Average Basic Shares Outstanding | 0.69% | 4.56% | 12.23% | 14.01% | 14.22% |
| Average Diluted Shares Outstanding | 0.69% | 4.56% | 9.43% | 14.01% | 14.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |